2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide

C26H29ClN2O4 — CID 46372777

IUPAC2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide
SMILESCC(C)(C)c1ccc2c(c1)N(CC(=O)NCC1CCCO1)C(=O)/C(=C\c1ccc(Cl)cc1)O2
InChIInChI=1S/C26H29ClN2O4/c1-26(2,3)18-8-11-22-21(14-18)29(16-24(30)28-15-20-5-4-12-32-20)25(31)23(33-22)13-17-6-9-19(27)10-7-17/h6-11,13-14,20H,4-5,12,15-16H2,1-3H3,(H,28,30)/b23-13+
InChIKeyTVZFBRRXISDDKG-YDZHTSKRSA-N
MW468.98 g/mol
LogP4.70
Rot. Bonds5

About 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide

2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide (PubChem CID 46372777) has the molecular formula C26H29ClN2O4 and a molecular weight of 468.98 g/mol. Its IUPAC name is 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide.

Molecular Properties

Compound Name2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide
PubChem CID46372777
Molecular FormulaC26H29ClN2O4
Molecular Weight468.98 g/mol
Exact Mass468.18
IUPAC Name2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide
SMILESCC(C)(C)c1ccc2c(c1)N(CC(=O)NCC1CCCO1)C(=O)/C(=C\c1ccc(Cl)cc1)O2
InChIInChI=1S/C26H29ClN2O4/c1-26(2,3)18-8-11-22-21(14-18)29(16-24(30)28-15-20-5-4-12-32-20)25(31)23(33-22)13-17-6-9-19(27)10-7-17/h6-11,13-14,20H,4-5,12,15-16H2,1-3H3,(H,28,30)/b23-13+
InChIKeyTVZFBRRXISDDKG-YDZHTSKRSA-N
XLogP4.70
TPSA67.87 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500468.98
LogP ≤ 54.70
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide?
The IUPAC name of 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide (CID 46372777) is 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide.
What is the SMILES notation for 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide?
The canonical SMILES for 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide is CC(C)(C)c1ccc2c(c1)N(CC(=O)NCC1CCCO1)C(=O)/C(=C\c1ccc(Cl)cc1)O2.
What is the InChIKey of 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide?
The InChIKey is TVZFBRRXISDDKG-YDZHTSKRSA-N. The full InChI is InChI=1S/C26H29ClN2O4/c1-26(2,3)18-8-11-22-21(14-18)29(16-24(30)28-15-20-5-4-12-32-20)25(31)23(33-22)13-17-6-9-19(27)10-7-17/h6-11,13-14,20H,4-5,12,15-16H2,1-3H3,(H,28,30)/b23-13+.
What are the key properties of 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide?
2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide has a molecular weight of 468.98 g/mol, XLogP of 4.70, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2E)-6-tert-butyl-2-[(4-chlorophenyl)methylidene]-3-oxo-1,4-benzoxazin-4-yl]-N-(oxolan-2-ylmethyl)acetamide is sourced from PubChem (CID 46372777), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).